nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2D6—Lomustine—brain cancer	0.143	0.303	CbGbCtD
Tramadol—CYP2D6—Hydroxyurea—brain cancer	0.108	0.23	CbGbCtD
Tramadol—CYP3A4—Temozolomide—brain cancer	0.107	0.227	CbGbCtD
Tramadol—CYP3A4—Lomustine—brain cancer	0.091	0.193	CbGbCtD
Tramadol—HTR2C—choroid plexus—brain cancer	0.0274	0.167	CbGeAlD
Tramadol—CYP3A4—Etoposide—brain cancer	0.022	0.0466	CbGbCtD
Tramadol—OPRM1—telencephalic ventricle—brain cancer	0.00917	0.0557	CbGeAlD
Tramadol—OPRD1—ganglion—brain cancer	0.00837	0.0508	CbGeAlD
Tramadol—HTR2C—telencephalic ventricle—brain cancer	0.00804	0.0489	CbGeAlD
Tramadol—Venlafaxine—CYP2C9—brain cancer	0.00642	0.695	CrCbGaD
Tramadol—OPRM1—ganglion—brain cancer	0.00571	0.0347	CbGeAlD
Tramadol—HTR2C—ganglion—brain cancer	0.00501	0.0304	CbGeAlD
Tramadol—SLC6A4—ganglion—brain cancer	0.00475	0.0288	CbGeAlD
Tramadol—GRIN3A—telencephalon—brain cancer	0.00458	0.0278	CbGeAlD
Tramadol—SLC6A2—ganglion—brain cancer	0.00418	0.0254	CbGeAlD
Tramadol—SLC6A4—hindbrain—brain cancer	0.0036	0.0219	CbGeAlD
Tramadol—OPRD1—telencephalon—brain cancer	0.00323	0.0196	CbGeAlD
Tramadol—GRIN3A—head—brain cancer	0.00285	0.0173	CbGeAlD
Tramadol—Dextromethorphan—CYP2C9—brain cancer	0.00281	0.305	CrCbGaD
Tramadol—GRIN3A—central nervous system—brain cancer	0.0026	0.0158	CbGeAlD
Tramadol—OPRM1—brainstem—brain cancer	0.00248	0.0151	CbGeAlD
Tramadol—OPRM1—telencephalon—brain cancer	0.0022	0.0134	CbGeAlD
Tramadol—HTR2C—brainstem—brain cancer	0.00218	0.0132	CbGeAlD
Tramadol—GRIN3A—brain—brain cancer	0.00207	0.0126	CbGeAlD
Tramadol—SLC6A4—brainstem—brain cancer	0.00206	0.0125	CbGeAlD
Tramadol—OPRD1—head—brain cancer	0.00201	0.0122	CbGeAlD
Tramadol—HTR2C—telencephalon—brain cancer	0.00193	0.0117	CbGeAlD
Tramadol—OPRK1—head—brain cancer	0.00193	0.0117	CbGeAlD
Tramadol—OPRD1—central nervous system—brain cancer	0.00183	0.0111	CbGeAlD
Tramadol—SLC6A4—telencephalon—brain cancer	0.00183	0.0111	CbGeAlD
Tramadol—SLC6A2—brainstem—brain cancer	0.00182	0.011	CbGeAlD
Tramadol—OPRK1—central nervous system—brain cancer	0.00176	0.0107	CbGeAlD
Tramadol—CYP2D6—hindbrain—brain cancer	0.00173	0.0105	CbGeAlD
Tramadol—OPRK1—cerebellum—brain cancer	0.00172	0.0104	CbGeAlD
Tramadol—CHRM3—telencephalon—brain cancer	0.00163	0.00991	CbGeAlD
Tramadol—SLC6A2—telencephalon—brain cancer	0.00161	0.00979	CbGeAlD
Tramadol—OPRM1—midbrain—brain cancer	0.00158	0.0096	CbGeAlD
Tramadol—OPRM1—spinal cord—brain cancer	0.00154	0.00937	CbGeAlD
Tramadol—HTR2C—medulla oblongata—brain cancer	0.00152	0.00922	CbGeAlD
Tramadol—OPRD1—brain—brain cancer	0.00146	0.00885	CbGeAlD
Tramadol—OPRK1—brain—brain cancer	0.0014	0.00848	CbGeAlD
Tramadol—OPRM1—endocrine gland—brain cancer	0.00139	0.00843	CbGeAlD
Tramadol—HTR2C—midbrain—brain cancer	0.00139	0.00842	CbGeAlD
Tramadol—OPRM1—head—brain cancer	0.00137	0.00833	CbGeAlD
Tramadol—HTR2C—spinal cord—brain cancer	0.00135	0.00822	CbGeAlD
Tramadol—SLC6A2—gonad—brain cancer	0.00134	0.00817	CbGeAlD
Tramadol—SLC6A4—midbrain—brain cancer	0.00131	0.00799	CbGeAlD
Tramadol—SLC6A4—spinal cord—brain cancer	0.00128	0.00779	CbGeAlD
Tramadol—SLC6A2—medulla oblongata—brain cancer	0.00127	0.00769	CbGeAlD
Tramadol—OPRM1—central nervous system—brain cancer	0.00125	0.0076	CbGeAlD
Tramadol—HTR2C—head—brain cancer	0.0012	0.00731	CbGeAlD
Tramadol—SLC6A4—endocrine gland—brain cancer	0.00115	0.00701	CbGeAlD
Tramadol—SLC6A4—head—brain cancer	0.00114	0.00693	CbGeAlD
Tramadol—HTR2C—central nervous system—brain cancer	0.0011	0.00667	CbGeAlD
Tramadol—SLC6A4—central nervous system—brain cancer	0.00104	0.00632	CbGeAlD
Tramadol—CHRM3—endocrine gland—brain cancer	0.00103	0.00625	CbGeAlD
Tramadol—SLC6A2—endocrine gland—brain cancer	0.00102	0.00618	CbGeAlD
Tramadol—CHRM3—head—brain cancer	0.00102	0.00617	CbGeAlD
Tramadol—SLC6A2—head—brain cancer	0.001	0.0061	CbGeAlD
Tramadol—CYP2D6—brainstem—brain cancer	0.000994	0.00604	CbGeAlD
Tramadol—OPRM1—brain—brain cancer	0.000993	0.00603	CbGeAlD
Tramadol—CYP2B6—gonad—brain cancer	0.000991	0.00602	CbGeAlD
Tramadol—CHRM3—central nervous system—brain cancer	0.000927	0.00564	CbGeAlD
Tramadol—SLC6A2—central nervous system—brain cancer	0.000916	0.00557	CbGeAlD
Tramadol—CYP2D6—telencephalon—brain cancer	0.000882	0.00536	CbGeAlD
Tramadol—HTR2C—brain—brain cancer	0.000871	0.00529	CbGeAlD
Tramadol—SLC6A4—brain—brain cancer	0.000826	0.00502	CbGeAlD
Tramadol—CYP2B6—endocrine gland—brain cancer	0.000749	0.00455	CbGeAlD
Tramadol—CYP2B6—head—brain cancer	0.000739	0.00449	CbGeAlD
Tramadol—CHRM3—brain—brain cancer	0.000736	0.00447	CbGeAlD
Tramadol—SLC6A2—brain—brain cancer	0.000727	0.00442	CbGeAlD
Tramadol—CYP2B6—central nervous system—brain cancer	0.000675	0.0041	CbGeAlD
Tramadol—CYP3A4—endocrine gland—brain cancer	0.000566	0.00344	CbGeAlD
Tramadol—CYP2D6—endocrine gland—brain cancer	0.000557	0.00338	CbGeAlD
Tramadol—CYP2D6—head—brain cancer	0.000549	0.00334	CbGeAlD
Tramadol—CYP2B6—brain—brain cancer	0.000536	0.00326	CbGeAlD
Tramadol—Somnolence—Procarbazine—brain cancer	0.000518	0.00151	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000516	0.00151	CcSEcCtD
Tramadol—Cramp muscle—Etoposide—brain cancer	0.000516	0.00151	CcSEcCtD
Tramadol—Haemoglobin—Carmustine—brain cancer	0.000515	0.00151	CcSEcCtD
Tramadol—Haemorrhage—Carmustine—brain cancer	0.000513	0.0015	CcSEcCtD
Tramadol—Ill-defined disorder—Hydroxyurea—brain cancer	0.000512	0.0015	CcSEcCtD
Tramadol—Anaemia—Hydroxyurea—brain cancer	0.00051	0.00149	CcSEcCtD
Tramadol—Hallucination—Carmustine—brain cancer	0.00051	0.00149	CcSEcCtD
Tramadol—Hypoaesthesia—Carmustine—brain cancer	0.00051	0.00149	CcSEcCtD
Tramadol—CYP3A4—central nervous system—brain cancer	0.00051	0.0031	CbGeAlD
Tramadol—Decreased appetite—Procarbazine—brain cancer	0.000506	0.00148	CcSEcCtD
Tramadol—Alanine aminotransferase increased—Etoposide—brain cancer	0.000506	0.00148	CcSEcCtD
Tramadol—Oedema peripheral—Carmustine—brain cancer	0.000505	0.00148	CcSEcCtD
Tramadol—Connective tissue disorder—Carmustine—brain cancer	0.000504	0.00147	CcSEcCtD
Tramadol—Fatigue—Procarbazine—brain cancer	0.000502	0.00147	CcSEcCtD
Tramadol—CYP2D6—central nervous system—brain cancer	0.000502	0.00305	CbGeAlD
Tramadol—Haemoglobin—Temozolomide—brain cancer	0.000498	0.00146	CcSEcCtD
Tramadol—Malaise—Hydroxyurea—brain cancer	0.000498	0.00146	CcSEcCtD
Tramadol—Pain—Procarbazine—brain cancer	0.000498	0.00146	CcSEcCtD
Tramadol—Constipation—Procarbazine—brain cancer	0.000498	0.00146	CcSEcCtD
Tramadol—Haemorrhage—Temozolomide—brain cancer	0.000496	0.00145	CcSEcCtD
Tramadol—Hepatitis—Temozolomide—brain cancer	0.000496	0.00145	CcSEcCtD
Tramadol—Dysphagia—Etoposide—brain cancer	0.000495	0.00145	CcSEcCtD
Tramadol—Visual impairment—Carmustine—brain cancer	0.000494	0.00145	CcSEcCtD
Tramadol—Hallucination—Temozolomide—brain cancer	0.000493	0.00144	CcSEcCtD
Tramadol—Hypoaesthesia—Temozolomide—brain cancer	0.000493	0.00144	CcSEcCtD
Tramadol—Pharyngitis—Temozolomide—brain cancer	0.000492	0.00144	CcSEcCtD
Tramadol—CYP2D6—cerebellum—brain cancer	0.00049	0.00298	CbGeAlD
Tramadol—Urinary tract disorder—Temozolomide—brain cancer	0.000489	0.00143	CcSEcCtD
Tramadol—Oedema peripheral—Temozolomide—brain cancer	0.000488	0.00143	CcSEcCtD
Tramadol—Bronchospasm—Etoposide—brain cancer	0.000487	0.00143	CcSEcCtD
Tramadol—Connective tissue disorder—Temozolomide—brain cancer	0.000487	0.00142	CcSEcCtD
Tramadol—Urethral disorder—Temozolomide—brain cancer	0.000486	0.00142	CcSEcCtD
Tramadol—Sweating increased—Etoposide—brain cancer	0.000483	0.00141	CcSEcCtD
Tramadol—Feeling abnormal—Procarbazine—brain cancer	0.00048	0.0014	CcSEcCtD
Tramadol—Eye disorder—Carmustine—brain cancer	0.000479	0.0014	CcSEcCtD
Tramadol—Convulsion—Hydroxyurea—brain cancer	0.000478	0.0014	CcSEcCtD
Tramadol—Visual impairment—Temozolomide—brain cancer	0.000478	0.0014	CcSEcCtD
Tramadol—Gastrointestinal pain—Procarbazine—brain cancer	0.000476	0.00139	CcSEcCtD
Tramadol—Flushing—Carmustine—brain cancer	0.000476	0.00139	CcSEcCtD
Tramadol—Erythema multiforme—Temozolomide—brain cancer	0.000469	0.00137	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000467	0.00137	CcSEcCtD
Tramadol—Discomfort—Hydroxyurea—brain cancer	0.000465	0.00136	CcSEcCtD
Tramadol—Eye disorder—Temozolomide—brain cancer	0.000463	0.00135	CcSEcCtD
Tramadol—Urticaria—Procarbazine—brain cancer	0.000463	0.00135	CcSEcCtD
Tramadol—Tinnitus—Temozolomide—brain cancer	0.000462	0.00135	CcSEcCtD
Tramadol—Abdominal pain—Procarbazine—brain cancer	0.00046	0.00135	CcSEcCtD
Tramadol—Body temperature increased—Procarbazine—brain cancer	0.00046	0.00135	CcSEcCtD
Tramadol—Cardiac disorder—Temozolomide—brain cancer	0.00046	0.00135	CcSEcCtD
Tramadol—Flushing—Temozolomide—brain cancer	0.00046	0.00135	CcSEcCtD
Tramadol—Arrhythmia—Carmustine—brain cancer	0.000458	0.00134	CcSEcCtD
Tramadol—Angiopathy—Temozolomide—brain cancer	0.00045	0.00132	CcSEcCtD
Tramadol—Mental disorder—Carmustine—brain cancer	0.000449	0.00131	CcSEcCtD
Tramadol—Infection—Hydroxyurea—brain cancer	0.000448	0.00131	CcSEcCtD
Tramadol—Immune system disorder—Temozolomide—brain cancer	0.000448	0.00131	CcSEcCtD
Tramadol—Mediastinal disorder—Temozolomide—brain cancer	0.000447	0.00131	CcSEcCtD
Tramadol—Malnutrition—Carmustine—brain cancer	0.000446	0.00131	CcSEcCtD
Tramadol—Erythema—Carmustine—brain cancer	0.000446	0.00131	CcSEcCtD
Tramadol—Chills—Temozolomide—brain cancer	0.000445	0.0013	CcSEcCtD
Tramadol—Pneumonia—Etoposide—brain cancer	0.000444	0.0013	CcSEcCtD
Tramadol—Nervous system disorder—Hydroxyurea—brain cancer	0.000442	0.00129	CcSEcCtD
Tramadol—Infestation NOS—Etoposide—brain cancer	0.000442	0.00129	CcSEcCtD
Tramadol—Infestation—Etoposide—brain cancer	0.000442	0.00129	CcSEcCtD
Tramadol—Thrombocytopenia—Hydroxyurea—brain cancer	0.000441	0.00129	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000438	0.00128	CcSEcCtD
Tramadol—Skin disorder—Hydroxyurea—brain cancer	0.000438	0.00128	CcSEcCtD
Tramadol—Acute coronary syndrome—Etoposide—brain cancer	0.000435	0.00127	CcSEcCtD
Tramadol—Renal failure—Etoposide—brain cancer	0.000434	0.00127	CcSEcCtD
Tramadol—Mental disorder—Temozolomide—brain cancer	0.000434	0.00127	CcSEcCtD
Tramadol—Myocardial infarction—Etoposide—brain cancer	0.000433	0.00127	CcSEcCtD
Tramadol—Back pain—Carmustine—brain cancer	0.000432	0.00126	CcSEcCtD
Tramadol—Erythema—Temozolomide—brain cancer	0.000431	0.00126	CcSEcCtD
Tramadol—Malnutrition—Temozolomide—brain cancer	0.000431	0.00126	CcSEcCtD
Tramadol—Stomatitis—Etoposide—brain cancer	0.000431	0.00126	CcSEcCtD
Tramadol—Anorexia—Hydroxyurea—brain cancer	0.00043	0.00126	CcSEcCtD
Tramadol—Hypersensitivity—Procarbazine—brain cancer	0.000429	0.00126	CcSEcCtD
Tramadol—Dysgeusia—Temozolomide—brain cancer	0.000422	0.00124	CcSEcCtD
Tramadol—Vision blurred—Carmustine—brain cancer	0.000421	0.00123	CcSEcCtD
Tramadol—Tremor—Carmustine—brain cancer	0.000418	0.00122	CcSEcCtD
Tramadol—Asthenia—Procarbazine—brain cancer	0.000418	0.00122	CcSEcCtD
Tramadol—Hepatobiliary disease—Etoposide—brain cancer	0.000418	0.00122	CcSEcCtD
Tramadol—Back pain—Temozolomide—brain cancer	0.000417	0.00122	CcSEcCtD
Tramadol—Anaemia—Carmustine—brain cancer	0.000413	0.00121	CcSEcCtD
Tramadol—Pruritus—Procarbazine—brain cancer	0.000412	0.00121	CcSEcCtD
Tramadol—Agitation—Carmustine—brain cancer	0.00041	0.0012	CcSEcCtD
Tramadol—Vision blurred—Temozolomide—brain cancer	0.000407	0.00119	CcSEcCtD
Tramadol—Tremor—Temozolomide—brain cancer	0.000404	0.00118	CcSEcCtD
Tramadol—Dyspnoea—Hydroxyurea—brain cancer	0.000402	0.00118	CcSEcCtD
Tramadol—Somnolence—Hydroxyurea—brain cancer	0.000401	0.00117	CcSEcCtD
Tramadol—Ill-defined disorder—Temozolomide—brain cancer	0.0004	0.00117	CcSEcCtD
Tramadol—Anaemia—Temozolomide—brain cancer	0.000399	0.00117	CcSEcCtD
Tramadol—Diarrhoea—Procarbazine—brain cancer	0.000398	0.00117	CcSEcCtD
Tramadol—CYP2D6—brain—brain cancer	0.000398	0.00242	CbGeAlD
Tramadol—Dyspepsia—Hydroxyurea—brain cancer	0.000397	0.00116	CcSEcCtD
Tramadol—Agitation—Temozolomide—brain cancer	0.000396	0.00116	CcSEcCtD
Tramadol—Hypoaesthesia—Etoposide—brain cancer	0.000395	0.00115	CcSEcCtD
Tramadol—Angioedema—Temozolomide—brain cancer	0.000394	0.00115	CcSEcCtD
Tramadol—Decreased appetite—Hydroxyurea—brain cancer	0.000392	0.00115	CcSEcCtD
Tramadol—Urinary tract disorder—Etoposide—brain cancer	0.000392	0.00115	CcSEcCtD
Tramadol—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000389	0.00114	CcSEcCtD
Tramadol—Malaise—Temozolomide—brain cancer	0.000389	0.00114	CcSEcCtD
Tramadol—Urethral disorder—Etoposide—brain cancer	0.000389	0.00114	CcSEcCtD
Tramadol—Fatigue—Hydroxyurea—brain cancer	0.000389	0.00114	CcSEcCtD
Tramadol—Vertigo—Temozolomide—brain cancer	0.000388	0.00113	CcSEcCtD
Tramadol—Convulsion—Carmustine—brain cancer	0.000387	0.00113	CcSEcCtD
Tramadol—Hypertension—Carmustine—brain cancer	0.000385	0.00113	CcSEcCtD
Tramadol—Pain—Hydroxyurea—brain cancer	0.000385	0.00113	CcSEcCtD
Tramadol—Constipation—Hydroxyurea—brain cancer	0.000385	0.00113	CcSEcCtD
Tramadol—Dizziness—Procarbazine—brain cancer	0.000385	0.00113	CcSEcCtD
Tramadol—Palpitations—Temozolomide—brain cancer	0.000381	0.00112	CcSEcCtD
Tramadol—Chest pain—Carmustine—brain cancer	0.00038	0.00111	CcSEcCtD
Tramadol—Myalgia—Carmustine—brain cancer	0.00038	0.00111	CcSEcCtD
Tramadol—Anxiety—Carmustine—brain cancer	0.000379	0.00111	CcSEcCtD
Tramadol—Cough—Temozolomide—brain cancer	0.000376	0.0011	CcSEcCtD
Tramadol—Erythema multiforme—Etoposide—brain cancer	0.000375	0.0011	CcSEcCtD
Tramadol—Convulsion—Temozolomide—brain cancer	0.000374	0.00109	CcSEcCtD
Tramadol—Hypertension—Temozolomide—brain cancer	0.000372	0.00109	CcSEcCtD
Tramadol—Feeling abnormal—Hydroxyurea—brain cancer	0.000371	0.00109	CcSEcCtD
Tramadol—Eye disorder—Etoposide—brain cancer	0.000371	0.00108	CcSEcCtD
Tramadol—Vomiting—Procarbazine—brain cancer	0.00037	0.00108	CcSEcCtD
Tramadol—Cardiac disorder—Etoposide—brain cancer	0.000368	0.00108	CcSEcCtD
Tramadol—Flushing—Etoposide—brain cancer	0.000368	0.00108	CcSEcCtD
Tramadol—Confusional state—Carmustine—brain cancer	0.000367	0.00107	CcSEcCtD
Tramadol—Arthralgia—Temozolomide—brain cancer	0.000367	0.00107	CcSEcCtD
Tramadol—Myalgia—Temozolomide—brain cancer	0.000367	0.00107	CcSEcCtD
Tramadol—Rash—Procarbazine—brain cancer	0.000367	0.00107	CcSEcCtD
Tramadol—Dermatitis—Procarbazine—brain cancer	0.000367	0.00107	CcSEcCtD
Tramadol—Anxiety—Temozolomide—brain cancer	0.000366	0.00107	CcSEcCtD
Tramadol—Headache—Procarbazine—brain cancer	0.000365	0.00107	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000365	0.00107	CcSEcCtD
Tramadol—Discomfort—Temozolomide—brain cancer	0.000363	0.00106	CcSEcCtD
Tramadol—Infection—Carmustine—brain cancer	0.000362	0.00106	CcSEcCtD
Tramadol—Angiopathy—Etoposide—brain cancer	0.00036	0.00105	CcSEcCtD
Tramadol—Dry mouth—Temozolomide—brain cancer	0.000359	0.00105	CcSEcCtD
Tramadol—Immune system disorder—Etoposide—brain cancer	0.000358	0.00105	CcSEcCtD
Tramadol—Mediastinal disorder—Etoposide—brain cancer	0.000357	0.00105	CcSEcCtD
Tramadol—Thrombocytopenia—Carmustine—brain cancer	0.000357	0.00104	CcSEcCtD
Tramadol—Body temperature increased—Hydroxyurea—brain cancer	0.000356	0.00104	CcSEcCtD
Tramadol—Chills—Etoposide—brain cancer	0.000356	0.00104	CcSEcCtD
Tramadol—Tachycardia—Carmustine—brain cancer	0.000356	0.00104	CcSEcCtD
Tramadol—Confusional state—Temozolomide—brain cancer	0.000355	0.00104	CcSEcCtD
Tramadol—Anaphylactic shock—Temozolomide—brain cancer	0.000352	0.00103	CcSEcCtD
Tramadol—Infection—Temozolomide—brain cancer	0.00035	0.00102	CcSEcCtD
Tramadol—Anorexia—Carmustine—brain cancer	0.000347	0.00102	CcSEcCtD
Tramadol—Nausea—Procarbazine—brain cancer	0.000346	0.00101	CcSEcCtD
Tramadol—Nervous system disorder—Temozolomide—brain cancer	0.000345	0.00101	CcSEcCtD
Tramadol—Thrombocytopenia—Temozolomide—brain cancer	0.000345	0.00101	CcSEcCtD
Tramadol—Skin disorder—Temozolomide—brain cancer	0.000342	0.001	CcSEcCtD
Tramadol—Hypotension—Carmustine—brain cancer	0.00034	0.000996	CcSEcCtD
Tramadol—Hyperhidrosis—Temozolomide—brain cancer	0.00034	0.000996	CcSEcCtD
Tramadol—Dysgeusia—Etoposide—brain cancer	0.000338	0.000989	CcSEcCtD
Tramadol—Anorexia—Temozolomide—brain cancer	0.000336	0.000982	CcSEcCtD
Tramadol—Back pain—Etoposide—brain cancer	0.000334	0.000977	CcSEcCtD
Tramadol—Hypersensitivity—Hydroxyurea—brain cancer	0.000332	0.000971	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Carmustine—brain cancer	0.000332	0.000971	CcSEcCtD
Tramadol—Muscle spasms—Etoposide—brain cancer	0.000332	0.000971	CcSEcCtD
Tramadol—Insomnia—Carmustine—brain cancer	0.00033	0.000964	CcSEcCtD
Tramadol—Paraesthesia—Carmustine—brain cancer	0.000327	0.000957	CcSEcCtD
Tramadol—Dyspnoea—Carmustine—brain cancer	0.000325	0.00095	CcSEcCtD
Tramadol—Somnolence—Carmustine—brain cancer	0.000324	0.000948	CcSEcCtD
Tramadol—Asthenia—Hydroxyurea—brain cancer	0.000323	0.000946	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000321	0.000938	CcSEcCtD
Tramadol—Ill-defined disorder—Etoposide—brain cancer	0.00032	0.000937	CcSEcCtD
Tramadol—Anaemia—Etoposide—brain cancer	0.000319	0.000933	CcSEcCtD
Tramadol—Insomnia—Temozolomide—brain cancer	0.000318	0.000932	CcSEcCtD
Tramadol—Decreased appetite—Carmustine—brain cancer	0.000317	0.000927	CcSEcCtD
Tramadol—Paraesthesia—Temozolomide—brain cancer	0.000316	0.000925	CcSEcCtD
Tramadol—Gastrointestinal disorder—Carmustine—brain cancer	0.000315	0.00092	CcSEcCtD
Tramadol—Dyspnoea—Temozolomide—brain cancer	0.000314	0.000918	CcSEcCtD
Tramadol—Somnolence—Temozolomide—brain cancer	0.000313	0.000916	CcSEcCtD
Tramadol—Constipation—Carmustine—brain cancer	0.000312	0.000912	CcSEcCtD
Tramadol—Pain—Carmustine—brain cancer	0.000312	0.000912	CcSEcCtD
Tramadol—Malaise—Etoposide—brain cancer	0.000311	0.000911	CcSEcCtD
Tramadol—Vertigo—Etoposide—brain cancer	0.00031	0.000907	CcSEcCtD
Tramadol—Dyspepsia—Temozolomide—brain cancer	0.00031	0.000907	CcSEcCtD
Tramadol—Diarrhoea—Hydroxyurea—brain cancer	0.000308	0.000902	CcSEcCtD
Tramadol—Decreased appetite—Temozolomide—brain cancer	0.000306	0.000895	CcSEcCtD
Tramadol—Gastrointestinal disorder—Temozolomide—brain cancer	0.000304	0.000889	CcSEcCtD
Tramadol—Fatigue—Temozolomide—brain cancer	0.000304	0.000888	CcSEcCtD
Tramadol—Loss of consciousness—Etoposide—brain cancer	0.000303	0.000888	CcSEcCtD
Tramadol—Cough—Etoposide—brain cancer	0.000301	0.000881	CcSEcCtD
Tramadol—Pain—Temozolomide—brain cancer	0.000301	0.000881	CcSEcCtD
Tramadol—Constipation—Temozolomide—brain cancer	0.000301	0.000881	CcSEcCtD
Tramadol—Feeling abnormal—Carmustine—brain cancer	0.0003	0.000878	CcSEcCtD
Tramadol—Convulsion—Etoposide—brain cancer	0.000299	0.000875	CcSEcCtD
Tramadol—Hypertension—Etoposide—brain cancer	0.000298	0.000872	CcSEcCtD
Tramadol—Dizziness—Hydroxyurea—brain cancer	0.000298	0.000872	CcSEcCtD
Tramadol—Gastrointestinal pain—Carmustine—brain cancer	0.000298	0.000872	CcSEcCtD
Tramadol—Chest pain—Etoposide—brain cancer	0.000294	0.00086	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000292	0.000854	CcSEcCtD
Tramadol—Discomfort—Etoposide—brain cancer	0.00029	0.00085	CcSEcCtD
Tramadol—Feeling abnormal—Temozolomide—brain cancer	0.00029	0.000849	CcSEcCtD
Tramadol—Abdominal pain—Carmustine—brain cancer	0.000288	0.000843	CcSEcCtD
Tramadol—Body temperature increased—Carmustine—brain cancer	0.000288	0.000843	CcSEcCtD
Tramadol—Gastrointestinal pain—Temozolomide—brain cancer	0.000288	0.000842	CcSEcCtD
Tramadol—Vomiting—Hydroxyurea—brain cancer	0.000287	0.000838	CcSEcCtD
Tramadol—Rash—Hydroxyurea—brain cancer	0.000284	0.000831	CcSEcCtD
Tramadol—Confusional state—Etoposide—brain cancer	0.000284	0.000831	CcSEcCtD
Tramadol—Dermatitis—Hydroxyurea—brain cancer	0.000284	0.000831	CcSEcCtD
Tramadol—Headache—Hydroxyurea—brain cancer	0.000282	0.000826	CcSEcCtD
Tramadol—Anaphylactic shock—Etoposide—brain cancer	0.000282	0.000824	CcSEcCtD
Tramadol—Infection—Etoposide—brain cancer	0.00028	0.000819	CcSEcCtD
Tramadol—Urticaria—Temozolomide—brain cancer	0.00028	0.000818	CcSEcCtD
Tramadol—Abdominal pain—Temozolomide—brain cancer	0.000278	0.000814	CcSEcCtD
Tramadol—Body temperature increased—Temozolomide—brain cancer	0.000278	0.000814	CcSEcCtD
Tramadol—Thrombocytopenia—Etoposide—brain cancer	0.000276	0.000807	CcSEcCtD
Tramadol—Tachycardia—Etoposide—brain cancer	0.000275	0.000804	CcSEcCtD
Tramadol—Skin disorder—Etoposide—brain cancer	0.000274	0.000801	CcSEcCtD
Tramadol—Hyperhidrosis—Etoposide—brain cancer	0.000272	0.000797	CcSEcCtD
Tramadol—Anorexia—Etoposide—brain cancer	0.000269	0.000786	CcSEcCtD
Tramadol—Hypersensitivity—Carmustine—brain cancer	0.000268	0.000785	CcSEcCtD
Tramadol—Nausea—Hydroxyurea—brain cancer	0.000268	0.000783	CcSEcCtD
Tramadol—Hypotension—Etoposide—brain cancer	0.000263	0.00077	CcSEcCtD
Tramadol—Asthenia—Carmustine—brain cancer	0.000261	0.000765	CcSEcCtD
Tramadol—Hypersensitivity—Temozolomide—brain cancer	0.000259	0.000759	CcSEcCtD
Tramadol—Paraesthesia—Etoposide—brain cancer	0.000253	0.00074	CcSEcCtD
Tramadol—Asthenia—Temozolomide—brain cancer	0.000253	0.000739	CcSEcCtD
Tramadol—Dyspnoea—Etoposide—brain cancer	0.000251	0.000735	CcSEcCtD
Tramadol—Somnolence—Etoposide—brain cancer	0.00025	0.000733	CcSEcCtD
Tramadol—Diarrhoea—Carmustine—brain cancer	0.000249	0.000729	CcSEcCtD
Tramadol—Pruritus—Temozolomide—brain cancer	0.000249	0.000729	CcSEcCtD
Tramadol—Decreased appetite—Etoposide—brain cancer	0.000245	0.000717	CcSEcCtD
Tramadol—Gastrointestinal disorder—Etoposide—brain cancer	0.000243	0.000712	CcSEcCtD
Tramadol—Fatigue—Etoposide—brain cancer	0.000243	0.000711	CcSEcCtD
Tramadol—Dizziness—Carmustine—brain cancer	0.000241	0.000705	CcSEcCtD
Tramadol—Pain—Etoposide—brain cancer	0.000241	0.000705	CcSEcCtD
Tramadol—Constipation—Etoposide—brain cancer	0.000241	0.000705	CcSEcCtD
Tramadol—Diarrhoea—Temozolomide—brain cancer	0.000241	0.000705	CcSEcCtD
Tramadol—Dizziness—Temozolomide—brain cancer	0.000233	0.000681	CcSEcCtD
Tramadol—Feeling abnormal—Etoposide—brain cancer	0.000232	0.000679	CcSEcCtD
Tramadol—Vomiting—Carmustine—brain cancer	0.000232	0.000678	CcSEcCtD
Tramadol—Gastrointestinal pain—Etoposide—brain cancer	0.00023	0.000674	CcSEcCtD
Tramadol—Rash—Carmustine—brain cancer	0.00023	0.000672	CcSEcCtD
Tramadol—Dermatitis—Carmustine—brain cancer	0.00023	0.000671	CcSEcCtD
Tramadol—Headache—Carmustine—brain cancer	0.000228	0.000668	CcSEcCtD
Tramadol—Vomiting—Temozolomide—brain cancer	0.000224	0.000655	CcSEcCtD
Tramadol—Urticaria—Etoposide—brain cancer	0.000224	0.000655	CcSEcCtD
Tramadol—Body temperature increased—Etoposide—brain cancer	0.000223	0.000652	CcSEcCtD
Tramadol—Abdominal pain—Etoposide—brain cancer	0.000223	0.000652	CcSEcCtD
Tramadol—Rash—Temozolomide—brain cancer	0.000222	0.000649	CcSEcCtD
Tramadol—Dermatitis—Temozolomide—brain cancer	0.000222	0.000649	CcSEcCtD
Tramadol—Headache—Temozolomide—brain cancer	0.000221	0.000645	CcSEcCtD
Tramadol—Nausea—Carmustine—brain cancer	0.000216	0.000633	CcSEcCtD
Tramadol—Nausea—Temozolomide—brain cancer	0.000209	0.000612	CcSEcCtD
Tramadol—Hypersensitivity—Etoposide—brain cancer	0.000208	0.000607	CcSEcCtD
Tramadol—Asthenia—Etoposide—brain cancer	0.000202	0.000591	CcSEcCtD
Tramadol—Pruritus—Etoposide—brain cancer	0.000199	0.000583	CcSEcCtD
Tramadol—Diarrhoea—Etoposide—brain cancer	0.000193	0.000564	CcSEcCtD
Tramadol—Dizziness—Etoposide—brain cancer	0.000186	0.000545	CcSEcCtD
Tramadol—Vomiting—Etoposide—brain cancer	0.000179	0.000524	CcSEcCtD
Tramadol—Rash—Etoposide—brain cancer	0.000178	0.00052	CcSEcCtD
Tramadol—Dermatitis—Etoposide—brain cancer	0.000177	0.000519	CcSEcCtD
Tramadol—Headache—Etoposide—brain cancer	0.000177	0.000516	CcSEcCtD
Tramadol—Nausea—Etoposide—brain cancer	0.000167	0.00049	CcSEcCtD
Tramadol—OPRD1—GPCR downstream signaling—TRPC6—brain cancer	2.59e-05	0.00201	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—PTCH1—brain cancer	2.47e-05	0.00192	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—SMO—brain cancer	2.47e-05	0.00192	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTCH2—brain cancer	2.45e-05	0.00191	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—SHH—brain cancer	2.44e-05	0.0019	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—OR14C36—brain cancer	2.38e-05	0.00185	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—OR4C12—brain cancer	2.38e-05	0.00185	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HES5—brain cancer	2.37e-05	0.00185	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—ABR—brain cancer	2.36e-05	0.00184	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—TRPC6—brain cancer	2.35e-05	0.00183	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—DTX2—brain cancer	2.35e-05	0.00183	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PTCH1—brain cancer	2.31e-05	0.0018	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—SMO—brain cancer	2.31e-05	0.0018	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STRADA—brain cancer	2.3e-05	0.00179	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—TRPC6—brain cancer	2.27e-05	0.00177	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—ABR—brain cancer	2.24e-05	0.00174	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ABR—brain cancer	2.19e-05	0.00171	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—SHH—brain cancer	2.14e-05	0.00166	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GLI2—brain cancer	2.12e-05	0.00165	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTCH2—brain cancer	2.07e-05	0.00161	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—TRPC6—brain cancer	2.06e-05	0.0016	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—ABR—brain cancer	2.03e-05	0.00158	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PTCH1—brain cancer	2.03e-05	0.00158	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—SMO—brain cancer	2.03e-05	0.00158	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—DTX2—brain cancer	2.02e-05	0.00157	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HES5—brain cancer	2.01e-05	0.00156	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GLI1—brain cancer	1.99e-05	0.00155	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STRADA—brain cancer	1.95e-05	0.00152	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—VAV1—brain cancer	1.94e-05	0.00151	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ABR—brain cancer	1.92e-05	0.0015	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—TRPC6—brain cancer	1.92e-05	0.00149	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SUFU—brain cancer	1.89e-05	0.00147	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GLI2—brain cancer	1.86e-05	0.00145	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GFAP—brain cancer	1.82e-05	0.00142	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—SHH—brain cancer	1.81e-05	0.00141	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTCH2—brain cancer	1.78e-05	0.00138	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—VAV1—brain cancer	1.76e-05	0.00137	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GLI1—brain cancer	1.75e-05	0.00136	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—TRPC6—brain cancer	1.74e-05	0.00136	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HEY1—brain cancer	1.73e-05	0.00134	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HES5—brain cancer	1.72e-05	0.00134	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PTCH1—brain cancer	1.71e-05	0.00133	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—SMO—brain cancer	1.71e-05	0.00133	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—VAV1—brain cancer	1.7e-05	0.00132	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—DLL1—brain cancer	1.69e-05	0.00132	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—TP53—brain cancer	1.69e-05	0.00132	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STRADA—brain cancer	1.67e-05	0.0013	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SUFU—brain cancer	1.66e-05	0.00129	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—TRPC6—brain cancer	1.65e-05	0.00128	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP2C9—brain cancer	1.63e-05	0.00127	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ABR—brain cancer	1.63e-05	0.00127	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GFAP—brain cancer	1.6e-05	0.00124	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GLI2—brain cancer	1.57e-05	0.00122	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—SHH—brain cancer	1.55e-05	0.00121	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—VAV1—brain cancer	1.54e-05	0.0012	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTCH2—brain cancer	1.53e-05	0.00119	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1.53e-05	0.00119	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HEY1—brain cancer	1.51e-05	0.00118	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—TRPC6—brain cancer	1.5e-05	0.00116	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—DLL1—brain cancer	1.49e-05	0.00116	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HES5—brain cancer	1.48e-05	0.00115	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GLI1—brain cancer	1.48e-05	0.00115	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—SMO—brain cancer	1.47e-05	0.00114	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PTCH1—brain cancer	1.47e-05	0.00114	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SHH—brain cancer	1.44e-05	0.00112	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STRADA—brain cancer	1.44e-05	0.00112	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—VAV1—brain cancer	1.44e-05	0.00112	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—TRPC6—brain cancer	1.42e-05	0.0011	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP2C9—brain cancer	1.4e-05	0.00109	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SUFU—brain cancer	1.4e-05	0.00109	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ABR—brain cancer	1.4e-05	0.00109	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TRPC6—brain cancer	1.39e-05	0.00108	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—BSG—brain cancer	1.39e-05	0.00108	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SMO—brain cancer	1.37e-05	0.00106	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTCH1—brain cancer	1.37e-05	0.00106	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GFAP—brain cancer	1.35e-05	0.00105	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GLI2—brain cancer	1.35e-05	0.00105	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—SHH—brain cancer	1.34e-05	0.00104	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.32e-05	0.00103	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—VAV1—brain cancer	1.31e-05	0.00102	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—TRPC6—brain cancer	1.29e-05	0.001	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HEY1—brain cancer	1.28e-05	0.000996	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GLI1—brain cancer	1.27e-05	0.000986	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PTCH1—brain cancer	1.27e-05	0.000985	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—SMO—brain cancer	1.27e-05	0.000985	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SHH—brain cancer	1.26e-05	0.000983	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—DLL1—brain cancer	1.26e-05	0.000977	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—VAV1—brain cancer	1.23e-05	0.000961	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—PIK3CG—brain cancer	1.23e-05	0.000958	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TRPC6—brain cancer	1.22e-05	0.000948	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ABR—brain cancer	1.2e-05	0.000935	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SUFU—brain cancer	1.2e-05	0.000935	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTCH1—brain cancer	1.2e-05	0.000932	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SMO—brain cancer	1.2e-05	0.000932	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—BSG—brain cancer	1.19e-05	0.000929	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—IDH1—brain cancer	1.19e-05	0.000929	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GLI2—brain cancer	1.16e-05	0.000903	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GFAP—brain cancer	1.16e-05	0.000902	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.14e-05	0.000887	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—VAV1—brain cancer	1.12e-05	0.000872	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PIK3CG—brain cancer	1.12e-05	0.00087	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HEY1—brain cancer	1.1e-05	0.000855	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GLI1—brain cancer	1.09e-05	0.000849	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NOTCH2—brain cancer	1.09e-05	0.000849	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—PIK3CG—brain cancer	1.08e-05	0.00084	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—DLL1—brain cancer	1.08e-05	0.000839	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SHH—brain cancer	1.07e-05	0.000831	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—VAV1—brain cancer	1.06e-05	0.000827	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VAV1—brain cancer	1.04e-05	0.00081	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SUFU—brain cancer	1.03e-05	0.000805	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TRPC6—brain cancer	1.03e-05	0.000801	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—IDH1—brain cancer	1.03e-05	0.000799	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTCH1—brain cancer	1.01e-05	0.000787	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SMO—brain cancer	1.01e-05	0.000787	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GFAP—brain cancer	9.98e-06	0.000777	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PIK3CG—brain cancer	9.81e-06	0.000763	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP2C9—brain cancer	9.76e-06	0.00076	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—VAV1—brain cancer	9.65e-06	0.000751	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOTCH2—brain cancer	9.57e-06	0.000745	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HEY1—brain cancer	9.46e-06	0.000736	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ENO2—brain cancer	9.44e-06	0.000734	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—DLL1—brain cancer	9.28e-06	0.000722	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SHH—brain cancer	9.17e-06	0.000713	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—PIK3CG—brain cancer	9.13e-06	0.00071	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VAV1—brain cancer	9.12e-06	0.00071	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HES1—brain cancer	8.95e-06	0.000696	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TRPC6—brain cancer	8.84e-06	0.000688	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTCH1—brain cancer	8.69e-06	0.000676	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SMO—brain cancer	8.69e-06	0.000676	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—IL2—brain cancer	8.67e-06	0.000674	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PDGFRA—brain cancer	8.52e-06	0.000663	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—BSG—brain cancer	8.3e-06	0.000646	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CG—brain cancer	8.29e-06	0.000645	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SPP1—brain cancer	8.27e-06	0.000644	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ENO2—brain cancer	8.12e-06	0.000632	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOTCH2—brain cancer	8.09e-06	0.000629	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SHH—brain cancer	7.89e-06	0.000614	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL2—brain cancer	7.87e-06	0.000612	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HES1—brain cancer	7.85e-06	0.000611	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	7.84e-06	0.00061	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VAV1—brain cancer	7.71e-06	0.0006	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TRPC6—brain cancer	7.61e-06	0.000592	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—IL2—brain cancer	7.6e-06	0.000591	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTCH1—brain cancer	7.48e-06	0.000582	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IRS2—brain cancer	7.48e-06	0.000582	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SMO—brain cancer	7.48e-06	0.000582	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PDGFRA—brain cancer	7.47e-06	0.000581	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SPP1—brain cancer	7.25e-06	0.000564	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—IDH1—brain cancer	7.14e-06	0.000555	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	7.12e-06	0.000554	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOTCH2—brain cancer	6.95e-06	0.000541	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL2—brain cancer	6.9e-06	0.000537	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	6.75e-06	0.000525	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HES1—brain cancer	6.63e-06	0.000516	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VAV1—brain cancer	6.62e-06	0.000515	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—APC—brain cancer	6.61e-06	0.000514	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CG—brain cancer	6.61e-06	0.000514	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IRS2—brain cancer	6.56e-06	0.00051	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—IL2—brain cancer	6.42e-06	0.0005	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2C9—brain cancer	6.38e-06	0.000497	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PDGFRA—brain cancer	6.31e-06	0.000491	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SPP1—brain cancer	6.13e-06	0.000477	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	6.13e-06	0.000477	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—EGFR—brain cancer	6.02e-06	0.000468	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOTCH2—brain cancer	5.98e-06	0.000465	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL2—brain cancer	5.83e-06	0.000454	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CG—brain cancer	5.79e-06	0.000451	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—APC—brain cancer	5.79e-06	0.000451	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VAV1—brain cancer	5.7e-06	0.000444	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HES1—brain cancer	5.7e-06	0.000443	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ENO2—brain cancer	5.64e-06	0.000439	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IRS2—brain cancer	5.54e-06	0.000431	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL2—brain cancer	5.52e-06	0.000429	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—BSG—brain cancer	5.43e-06	0.000422	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PDGFRA—brain cancer	5.42e-06	0.000422	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EGFR—brain cancer	5.28e-06	0.000411	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SPP1—brain cancer	5.26e-06	0.00041	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RELA—brain cancer	5.16e-06	0.000402	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ERBB2—brain cancer	5.13e-06	0.000399	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL2—brain cancer	5.01e-06	0.00039	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HES1—brain cancer	4.9e-06	0.000382	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—APC—brain cancer	4.9e-06	0.000381	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CG—brain cancer	4.9e-06	0.000381	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IRS2—brain cancer	4.76e-06	0.00037	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL2—brain cancer	4.75e-06	0.00037	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PDGFRA—brain cancer	4.67e-06	0.000363	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—IDH1—brain cancer	4.67e-06	0.000363	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL2—brain cancer	4.65e-06	0.000362	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SPP1—brain cancer	4.53e-06	0.000353	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCND1—brain cancer	4.53e-06	0.000353	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RELA—brain cancer	4.53e-06	0.000352	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ERBB2—brain cancer	4.5e-06	0.00035	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CTNNB1—brain cancer	4.49e-06	0.000349	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—brain cancer	4.46e-06	0.000347	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CG—brain cancer	4.33e-06	0.000337	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL2—brain cancer	4.31e-06	0.000336	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CG—brain cancer	4.2e-06	0.000327	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APC—brain cancer	4.2e-06	0.000327	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IRS2—brain cancer	4.1e-06	0.000319	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—brain cancer	4.08e-06	0.000317	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—brain cancer	3.97e-06	0.000309	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—brain cancer	3.95e-06	0.000307	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CTNNB1—brain cancer	3.94e-06	0.000306	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—brain cancer	3.91e-06	0.000304	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—brain cancer	3.83e-06	0.000298	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RELA—brain cancer	3.83e-06	0.000298	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ERBB2—brain cancer	3.8e-06	0.000296	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CG—brain cancer	3.72e-06	0.00029	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ENO2—brain cancer	3.69e-06	0.000287	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—brain cancer	3.64e-06	0.000283	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CG—brain cancer	3.62e-06	0.000282	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APC—brain cancer	3.62e-06	0.000282	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—brain cancer	3.56e-06	0.000277	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—brain cancer	3.46e-06	0.00027	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—brain cancer	3.45e-06	0.000268	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—brain cancer	3.43e-06	0.000267	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—brain cancer	3.36e-06	0.000261	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CTNNB1—brain cancer	3.33e-06	0.000259	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—brain cancer	3.3e-06	0.000257	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RELA—brain cancer	3.29e-06	0.000256	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ERBB2—brain cancer	3.26e-06	0.000254	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—brain cancer	3.19e-06	0.000248	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—brain cancer	3.12e-06	0.000243	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—brain cancer	2.99e-06	0.000232	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—brain cancer	2.96e-06	0.00023	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—brain cancer	2.93e-06	0.000228	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—brain cancer	2.9e-06	0.000226	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—brain cancer	2.88e-06	0.000224	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CTNNB1—brain cancer	2.86e-06	0.000222	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RELA—brain cancer	2.83e-06	0.00022	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ERBB2—brain cancer	2.81e-06	0.000219	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—brain cancer	2.69e-06	0.00021	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—brain cancer	2.64e-06	0.000205	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—brain cancer	2.62e-06	0.000204	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CG—brain cancer	2.59e-06	0.000201	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—brain cancer	2.55e-06	0.000198	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—brain cancer	2.51e-06	0.000196	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—brain cancer	2.49e-06	0.000194	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—brain cancer	2.48e-06	0.000193	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CTNNB1—brain cancer	2.46e-06	0.000191	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—brain cancer	2.31e-06	0.00018	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—brain cancer	2.26e-06	0.000176	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—brain cancer	2.21e-06	0.000172	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—brain cancer	2.16e-06	0.000168	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—brain cancer	2.14e-06	0.000167	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—brain cancer	1.99e-06	0.000155	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—brain cancer	1.95e-06	0.000152	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—brain cancer	1.9e-06	0.000148	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CG—brain cancer	1.69e-06	0.000132	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—brain cancer	1.64e-06	0.000127	CbGpPWpGaD
